Corvus Pharmaceuticals (NASDAQ:CRVS) reported quarterly losses of $(0.24) per share. This is a 27.27 percent increase over losses of $(0.33) per share from the same period last year.
Tesla, Amazon, Lucid, Wayfair, Sumo Logic: Why These 5 Stocks Are Drawing Investors’ Attention Today
Major Wall Street indices closed in the green on Monday as investors and traders began considering the possibility of a slowdown in the pace of the Federal Reserve’s rate hikes.
